Jason Moss

Jason Moss has over 17 years of experience in the pharmaceutical industry. Jason is currently serving as the Head of Chemical Development & Manufacturing at ADC Therapeutics since May 2023. Prior to this, they worked as the Director of External Alternative CMC Development at Boehringer Ingelheim from February 2022 to May 2023. Jason also held the position of Director of External Process Development at Seagen from October 2020 to February 2022. Before that, they had a diverse range of roles at BioMarin Pharmaceutical Inc., including Director of Chemical Development & Manufacturing, Director of Drug Substance Contract Manufacturing, and Associate Director of Drug Substance Contract Manufacturing. Jason also worked as a Senior Director of Process Chemistry & Manufacturing, and Director of Radiopharmaceutical Process Development & Manufacturing at Progenics Pharmaceuticals Inc. Additionally, they have experience as a Technical Manager at Bachem and as a Director of Research & Process Development at PolyPeptide Group. Jason started their career as a Senior Scientist & Team Leader at Roche.

Jason Moss earned a Bachelor of Science (BS) degree in Chemistry from Duke University from 1996 to 2000. Following this, they pursued a Doctor of Philosophy (PhD) degree in Chemistry from Scripps Research between 2000 and 2005.